Company Filing History:
Years Active: 2006
Title: The Innovations of Peter Colon McDonnell
Introduction
Peter Colon McDonnell is an accomplished inventor based in Thousand Oaks, CA. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins for medical applications. His work focuses on addressing TNF-related disorders, which are critical areas of research in the medical community.
Latest Patents
Peter Colon McDonnell holds a patent for "Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders." This invention relates to novel proteins with TNF-receptor antagonist activity and nucleic acids encoding these proteins. The invention further includes TNF-receptor proteins with reduced immunogenicity and their use in treating TNF-related disorders. He has 1 patent to his name.
Career Highlights
Peter is currently employed at Xencor, Inc., a company known for its innovative approaches in the field of biopharmaceuticals. His work at Xencor has allowed him to contribute to groundbreaking research and development in therapeutic proteins.
Collaborations
Throughout his career, Peter has collaborated with notable colleagues, including Arthur J Chirino and Peizhi Luo. These collaborations have enhanced the scope and impact of his research.
Conclusion
Peter Colon McDonnell's contributions to biotechnology and his innovative patent work exemplify the importance of research in developing treatments for complex medical conditions. His ongoing efforts continue to pave the way for advancements in the field.